Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1452798

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1452798

Global RNA Analysis Market Size, Share, Growth Analysis, By Technology(Real Time-PCR Technology, Microarray Technology), By Product, By Application - Industry Forecast 2024-2031

PUBLISHED:
PAGES: 219 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global RNA Analysis Market size was valued at USD 15.5 billion in 2022 and is poised to grow from USD 16.12 billion in 2023 to USD 22.06 billion by 2031, growing at a CAGR of 4.00% during the forecast period (2024-2031).

The market is experiencing a surge driven by the growing adoption of mineral supplements to manage chronic conditions prevalent in a significant portion of the population, such as cancer, osteoporosis, anemia, and osteoporosis. Major pharmaceutical companies are actively engaging in social campaigns to promote healthier lifestyles and supplement usage. For instance, in February 2023, Torrent Pharmaceuticals Ltd launched the TV campaign #BeShelcalStrong, aiming to raise awareness about calcium deficiency and its impact on daily life. The rise in sedentary lifestyles and unhealthy diets has resulted in more people facing nutritional deficiencies, leading to issues like fatigue, weak bones, and compromised immune systems. Government initiatives promoting healthier lifestyles further contribute to market growth. Key players are focusing on innovative product development and exploring exotic ingredients, while the popularity of plant-based products presents additional growth opportunities. Amid the COVID-19 pandemic, mineral supplements witnessed increased demand, as research indicated the virus disproportionately affected individuals with mineral deficiencies. Despite this positive trend, the market faces challenges from counterfeit product sales, driven by economic crises and political conflicts disrupting the supply chain and leading to the proliferation of locally produced, inexpensive items.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global RNA Analysis Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global RNA Analysis Market Segmental Analysis

The global RNA analysis market is segmented on the basis of technology, product, application, end - use, region. By technology, the market is segmented real time-pcr (QPCR) technology, microarray technology, sequencing technology, and others. By product, the market is segmented into instruments, kits & reagents, cho media mirna & sirna, reverse transcriptases & rt-pcr, rna interference, rna extraction & purification, others, services. By application, the market is segmented into construction of rna expression atlas, infectious diseases & pathogenesis, epigenetics, alternative rna splicing, rna structure & molecular dynamics, development & delivery of rna therapeutics, others. By end - use, the market is segmented into government institutes & academic centers, contract research organizations (CROs), pharmaceutical & biotechnology companies, hospitals & clinics. By region, the market is segmented into North America, Europe, Latin America, Asia- Pacific, Middle East and Africa.

Drivers of the Global RNA Analysis Market

The pharmaceutical and biotech industries extensively depend on RNA analysis for the advancement of targeted therapies, personalized medicine, and novel drug candidates. This heightened reliance has generated significant demand for RNA analysis techniques within these sectors.

Restraints in the Global RNA Analysis Market

Analyzing RNA sequencing data requires intricate bioinformatics expertise and resources, posing a potential barrier to its widespread adoption in certain environments. The complexity of the process may limit accessibility and implementation in settings where specialized skills and dedicated resources may be scarce.

Market Trends of the Global RNA Analysis Market

The progress in long-read sequencing technologies has empowered the precise sequencing of entire RNA molecules, thereby advancing our comprehension of alternative splicing, isoforms, and intricate gene structures.

Product Code: SQMIG35H2192

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global RNA Analysis Market by Technology

  • Market Overview
  • Real Time-PCR (qPCR) Technology
  • Microarray Technology
  • Sequencing Technology
  • Others

Global RNA Analysis Market by Product

  • Market Overview
  • Instruments
  • Kits & Reagents
  • CHO Media miRNA & siRNA
  • Reverse Transcriptases & RT-PCR
  • RNA Extraction & Purification
  • RNA Interference
  • Others
  • Services

Global RNA Analysis Market by Application

  • Market Overview
  • Construction of RNA Expression Atlas
  • Epigenetics
  • Infectious Diseases & Pathogenesis
  • Alternative RNA Splicing
  • RNA Structure & Molecular Dynamics
  • Development & Delivery of RNA Therapeutics
  • Others

Global RNA Analysis Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Thermo Fisher Scientific Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Illumina, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Qiagen AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PerkinElmer, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eurofins Scientific SE (Luxembourg)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Genewiz (a Brooks Life Sciences Company) (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Promega Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fluidigm Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Oxford Nanopore Technologies Ltd. (United Kingdom)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Takara Bio Inc. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zymo Research Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BGI Group (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NuGEN Technologies, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lexogen GmbH (Austria)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pacific Biosciences of California, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche Diagnostics (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Techne Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!